$542.18
7.461.4%
Últ. Act.: Nov 2, 4:04 PM
Chemed (CHE) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Chemed (CHE) publicó su última previsión de octubre 27, 2026 para fiscal year 2026. La compañía estimó ingresos en un rango de para el período.
En comparación con la previsión anterior, Chemed elevado redujo su previsión de BPA desde un rango anterior de $24 - $24.75.
Chemed ha emitido 13 actualizaciones de orientación entre el febrero 23, 2023 y el julio 28, 2026. During this period, the company raised its outlook 5 times and lowered it 3 times, providing investors with insight into management's evolving expectations.
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $6.33 | $5.50 | $5.21 | $6.85 |
| Actual | $6.75 | $6.06 | $5.65 | $6.42 |
| Surprise | +6.64% | +10.2% | +8.45% | -6.28% |
| Revenue | ||||
| Estimate | $684.0M | $664.2M | $648.0M | $657.9M |
| Actual | $690.9M | $673.3M | $657.5M | $639.3M |
| Surprise | +1.01% | +1.36% | +1.46% | -2.82% |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $7.28 | $6.03 | $5.98 | $6.36 |
| Revenue | ||||
| Consensus | $711.6M | $711.6M | — | — |
| Trimestre Fiscal | Fecha reportada | EPS real | EPS estimado | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $6.75 | $6.33 | 6.64 % |
| Q2 | Jul 28, 2026 | $6.06 | $5.50 | 10.2 % |
| Q1 | Apr 23, 2026 | $5.65 | $5.21 | 8.45 % |
| Q4 | Feb 25, 2026 | $6.42 | $6.85 | -6.28 % |
| Trimestre Fiscal | Fecha reportada | Ingresos reales | Ingresos estimados | Sorpresa % |
|---|---|---|---|---|
| Q3 | Oct 27, 2026 | $690.94M | $684.04M | 1.01 % |
| Q2 | Jul 28, 2026 | $673.25M | $664.21M | 1.36 % |
| Q1 | Apr 23, 2026 | $657.51M | $648.04M | 1.46 % |
| Q4 | Feb 25, 2026 | $639.34M | $657.88M | -2.82 % |